Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...

Ahmedabad: Zydus Lifesciences Limited said it plans to launch semaglutide injection in India under the brand names Semaglyn, Mashema and Alterme after.

DUBLIN--(BUSINESS WIRE)--The "India Large Volume Parenteral (LVP) Market Analysis Report By Volume, By Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), By End Use ...